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Background: Evidence from epidemiological studies has demonstrated that a shorter or longer duration of
nighttime sleep may increase the risk of metabolic syndrome. Little is known about the association between
daily sleep duration, including nighttime sleep and daytime napping duration, and metabolic syndrome. We
aimed to examine the association between daily sleep duration and metabolic syndrome and its components in
middle-aged and older Chinese adults using data from the Dongfeng-Tongji Cohort study.
Methods: A total of 25,184 participants (mean age 63.6 years) who completed the baseline questionnaire, physical
examination and laboratory tests were included in this analysis. Daily sleep duration was calculated by summing up
nighttime sleep duration and daytime napping duration. The metabolic syndrome was defined using the
International Diabetes Federation criteria. Logistic regression models were used to investigate the association
between daily sleep duration and the risk of metabolic syndrome and its components.
Results: Of the participants, 8,046 (31.9%) had metabolic syndrome. Females had a higher prevalence (38.6%)
of metabolic syndrome than males (23.9%). Female participants with longer daily sleep duration (≥8 hours, all
P < 0.05) per day had a higher risk of metabolic syndrome compared with those sleeping 7–7.9 hours, adjusting
for potential confounders. Longer daily sleep was positively associated with individual components of metabolic
syndrome except central obesity in females, and was only positively associated with HDL-C in males. Further
analysis revealed that a longer duration of daytime napping (≥90 minutes, P < 0.05) was associated with the risk of
metabolic syndrome in females. However, nighttime sleep duration was not associated with the risk of metabolic
syndrome in either males or females.
Conclusions: Our findings suggested that longer daytime napping duration rather than nighttime sleeping
duration was associated with increased risk of metabolic syndrome in females. The findings have significant
implications for further studies to explore the appropriate sleep duration for middle-aged and older adults.
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Metabolic syndrome (MetS), a clustering of physiologic-
ally related cardiovascular risk factors, including central
adiposity, dyslipidemia, elevated blood pressure and in-
creased glucose level, is a critical public health problem
worldwide [1]. The syndrome is closely correlated with
the development of chronic kidney disease, cardiovascu-
lar disease, and a higher risk of all-cause mortality [2-4].
In China, the age-standardized prevalence of MetS was
9.8% in males and 17.8% in females [5]. Given high
prevalence of MetS, it is significant to identify modifiable
risk factors to prevent MetS.
Sleep is a basic need for human, and closely related to
the body’s metabolism. Previous studies have indicated
that short or long sleep duration is associated with an
increased risk for MetS, but the findings are not consist-
ent [6]. Studies have demonstrated that older adults had
different sleep pattern compared with younger adults
[7,8]. A meta-analysis performed by Flyd et al. found
that sleep duration increased with age while sleep distur-
bances also increased [7], suggesting that older adults
may have more daily sleep duration throughout the day.
However, to date, there is little evidence about the ef-
fects of daily sleep duration on human health outcomes
for older adults.
Daytime napping is traditionally regarded as a healthy
life behavior and is especially good for older adults in
China. The percentage of older Chinese adults who
practice habitual daytime napping reaches 61.7% in men
and 46.8% in women [9]. Accumulative evidence showed
that daytime napping might be a marker of underlying
health risks. A large cohort in British revealed that ex-
cessive daytime napping was associated with higher risk
of mortality from all-cause and respiratory diseases [10].
Xu et al. demonstrated an independent association be-
tween longer durations of daytime sleep and the risk of
diabetes in older adults [11]. Given the high prevalence
of daytime napping for older adults in China, it is of
great importance to examine the effects of daytime nap-
ping for health outcomes.
Evidence from studies have found different effects of
daytime napping and nighttime sleep for health [11,12],
therefore, in this study, we aimed to examine the associa-
tions between daily sleep duration, including daytime
napping and nighttime sleep with MetS in a Chinese
middle-aged and older population based on the data from
the Dongfeng-Tongji cohort study of retired workers.
Methods
Study participants
Data for our analysis was derived from the Dongfeng-
Tongji Cohort study (DFTJ cohort) which was initiated
in 2008 among retired employees of Dongfeng Motor
Corporation (DMC) in Shiyan City, Hubei Province. Therationale, design, and methods of the DFTJ cohort have
previously been described in detail [13]. Between 2008
and 2010, 87% (27009/31000) of the invited retired em-
ployees responded to the study and completed baseline
information, medical examinations and provided blood
samples. For current analysis, the participants who had
missing data on sleep habits or the determination of the
status of MetS were excluded. Thus, the final sample in-
cluded 25184 subjects. The demographic characteristics
including sex and age were similar between individuals
included in the current study and those excluded. This
study was approved by the Medical Ethics Committee of
the School of Public Health, Tongji Medical College,
Huazhong University of Science and Technology and
Dongfeng General Hospital, DMC. All participants
signed an informed consent form.
Assessment of MetS
We classified participants as having MetS if they have cen-
tral adiposity (defined as waist circumference ≥ 90 cm for
Chinese males and ≥ 80 cm for Chinese females) plus any
two of the following four factors according to the new
International Diabetes Federation (IDF) definition [1]: a. tri-
glycerides (TG) ≥1.7 mmol/L or specific treatment for this
lipid abnormality; b. high-density lipoprotein cholesterol
(HDL-C) <1.03 mmol/L in males or < 1.29 mmol/L in fe-
males or specific treatment for this lipid abnormality; c. sys-
tolic blood pressure (SBP) ≥ 130 mmHg or diastolic blood
pressure (DBP) ≥ 85 mm Hg or treatment of previously di-
agnosed hypertension; d. fasting plasma glucose (FPG) ≥
5.6 mmol/L or previously diagnosed type 2 diabetes.
Assessment of nighttime sleep, daytime napping and
daily sleep
Nighttime sleep duration was assessed by asking: “On aver-
age, how many hours and minutes do you sleep per night?”.
Nighttime sleep duration was classified as <7 hours, 7–7.9
hours, 8–8.9 hours, and ≥9 hours. Habitual daytime nappers
were defined as those who had taken a planned or regular
nap as a habit more than three times per week after lunch
over the past twelve months. Daytime napping was assessed
by asking “Do you have a habit of taking a nap after lunch?”
Those who reported “Yes” were further asked about the
average duration of their naps. Daytime napping duration
was categorized as no daytime napping, <30 minutes, 30–
59 minutes, 60–89 minutes, and ≥90 minutes. Additionally,
we computed daily sleep duration by summing up night-
time sleep duration and daytime napping duration, and
we categorized it into five categories: <7 hours, 7–7.9 hours,
8–8.9 hours, and 9–9.9 hours and ≥10 hours.
Assessment of covariates
Demographic information on age, sex, education level
(elementary or below, junior high school, high school,
Table 1 The characteristics of study participants with and





Characteristics (n = 17,138) (n = 8,046) P
Age (year) 64.6 ± 7.7 63.2 ± 7.8 <0.001
Sex <0.001
Male (%) 2720 (33.8) 8650 (50.5)
Female (%) 5326 (66.2) 8488 (49.5)
Marital status <0.001
Married (%) 7025 (87.5) 15518 (90.8)
Widowed (%) 845 (10.5) 1172 (6.9)
Unmarried (%) 22 (0.3) 54 (0.3)
Divorced (%) 133 (1.7) 350 (2.0)
Education <0.001
Elementary or below (%) 2789 (34.9) 4598 (27.1)
Junior high school (%) 2922 (36.6) 6058 (35.6)
High school (%) 1641 (20.6) 4362 (25.7)
College or above (%) 630 (7.9) 1979 (11.6)
Physical activity (%) 6454 (80.2) 14067 (82.1) <0.001
Current smoker (%) 1011 (12.7) 3496 (20.5) <0.001
Current drinker (%) 1275 (15.9) 3997 (23.3) <0.001
Self-reported medical history
Coronary heart disease (%) 1775 (22.3) 2121 (12.5) <0.001
Myocardial infarction (%) 278 (3.5) 423 (2.5) <0.001
Stroke (%) 443 (5.6) 605 (3.6) <0.001
Hypertension (%) 4623 (57.5) 5023 (52.1) <0.001
Diabetes mellitus (%) 1712 (21.3) 1383 (8.1) <0.001
Family history of diabetes (%) 470 (6.0) 64.4 (5.1) 0.004
Family history of hypertension (%) 2008 (25.3) 3498 (20.8) <0.001
Body mass index (kg/m2) 27.0 ± 3.1 23.3 ± 2.9 <0.001
Waist circumference (cm) 91.0 ± 7.5 79.3 ± 7.9 <0.001
Fasting plasma glucose (mmol/L) 6.6 ± 2.1 5.8 ± 1.5 <0.001
Systolic blood pressure (mmHg) 136.1 ± 18.0 126.6 ± 18.1 <0.001
Diastolic blood pressure (mmHg) 80.8 ± 11.1 76.3 ± 10.5 <0.001
HDL-C (mmol/L) 1.3 ± 0.4 1.5 ± 0.4 <0.001
Triglycerides (mmol/L) 5.3 ± 1.0 5.1 ± 0.9 <0.001
Data are presented as mean ± SD or number (percentage).
Abbreviations: MetS metabolic syndrome, HDL-C high-density lipoprotein
cholesterol.
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unmarried, widowed, divorced) was included in the
questionnaire. History of physician-diagnosed chronic
diseases and history of medication were also obtained.
The criteria for family history of diabetes or hyperten-
sion were having at least one first-degree relative with a
diagnosis of diabetes or hypertension. Health-related
habits on smoking status, alcohol drinking status, and
physical activity was also obtained. Physical activity was
defined as those who exercise more than 20 min per day
and more than three times per week over the last six
months. The anthropometric and laboratory data in-
cluded weight, height, waist circumference, systolic and
diastolic blood pressure, high density lipoprotein, and
triglyceride. Body mass index was calculated as weight in
kilograms divided by height in meters squared.
Statistical analysis
Numerical variables were summarized as mean ± SD
and categorical data were presented as proportion (%).
Student t-tests were used to examine difference in
means for the numerical data between participants with
MetS and those without MetS, and Chi-square tests
were used for categorical data. According to several
studies, the prevalence of MetS displayed a gender dif-
ference that females have a higher prevalence of MetS
than males [5,14]. Moreover, females reported to have
more sleep disturbances than males in older adults [15].
Therefore, we conducted a gender-stratified analysis. Lo-
gistic regression analyses were used to estimate the odds
ratios (ORs) and 95% confidence intervals (95% CIs) of
daily sleep duration with MetS in males and females,
respectively. We used participants with daily sleep
duration of 7–7.9 hours as the reference group. Model 1
was adjusted for demographic factors (age, marriage,
education), heath-related life behaviors (smoking status,
drinking status, physical activity), self-reported physician-
diagnosed chronic diseases and a family history of diabetes
or hypertension. Model 2 was adjusted for the variables
in Model 1 plus BMI. Moreover, to better understand
and interpret the results of the association between
daily sleep duration groups and MetS, we further ex-
plored the effects of daytime napping duration or night-
time sleep duration on MetS by performing logistic
regression analyses adjusting for covariates similar to
the above-mentioned models. We used participants
with nighttime sleep duration of 7–7.9 hours and those
who did not nap in the daytime as references respect-
ively in examining the associations among nighttime
sleep duration and daytime napping duration with
MetS. In addition, multivariable logistic regression was
also used to test the relationship between daily sleep dur-
ation and the components of MetS in males and females,
respectively. All statistical analysis was performed usingSPSS software (version 11.0). Associations were consid-
ered statistically significant at P < 0.05.
Results
Of the 25,184 participants (11,370 males, 13,814 fe-
males), 8,046 (31.9%) had MetS, females had a higher
prevalence (38.6%) of metabolic syndrome than males
(23.9%). Participants with MetS were more likely to be
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(Table 1). A higher proportion of participants with MetS
had physician diagnosed chronic diseases (all P < 0.001
for listed diseases) compare with those without MetS. In
addition, participants with MetS were more likely to
have higher blood pressure, higher level of triglycerides,
and higher body mass index.
Table 2 presents the prevalence of MetS in each sleep
duration category by gender. Using Chi-square test, we
found a higher prevalence of MetS in participants with
longer duration of daily sleeping than those with daily
sleep duration of 7–7.9 hours in females. There was sta-
tistically significance between different nighttime sleep
groups and the prevalence of MetS in females. Moreover,
female participants with longer duration of daytime nap-
ping had a higher prevalence of MetS compared with
those who did not nap. Daily sleep duration, nighttime
sleep duration and daytime duration had no effects on
the prevalence of MetS in males.
The associations between duration of daily sleep and
Mets stratified by genders were displayed in Table 3. Model
1 showed that females participants with a daily sleep dur-
ation of 8–8.9 hours (OR, 1.16 [95% CI, 1.04-1.30]), 9–9.9
hours (OR, 1.22 [95% CI, 1.08-1.36]), and ≥10 hours (OR,
1.29 [95% CI, 1.13-1.46]) had a significantly higher odds ra-
tio (OR) for MetS compared with females with daily sleep
duration of 7–7.9 hours after adjustment for demographic
factors (age, marriage, education), heath-related life behav-
iors (smoking status, drinking status, physical activity), self-Table 2 Prevalence of metabolic syndrome by sleep duration
Male
Non-MetS MetS
Daily sleep duration (hours)
<7 236 (72.6) 89 (27.4
7-7.9 1048 (76.4) 324 (23
8-8.9 2652 (76.4) 818 (23
9-9.9 2772 (77.0) 827 (23
≥10 1942 (74.6) 662 (25
Nighttime sleep duration (hours)
<7 599 (73.0) 222 (27
7-7.9 2346 (76.3) 727 (23
8-8.9 3510 (76.4) 1083 (2
≥9 2195 (76.1) 688 (23
Daytime napping duration (minutes)
None 2426 (77.6) 700 (22
<30 218 (74.9) 73 (25.1
30-59 1281 (76.8) 386 (23
60-89 2625 (75.6) 849 (24
≥90 2100 (74.7) 712 (25
Abbreviations: MetS metabolic syndrome.reported physician-diagnosed chronic diseases and a family
history of diabetes or hypertension. In model 2, after
adjusting for BMI which is a main known risk factor for
MetS, the ORs were 1.20 (95% CI, 1.06-1.37), 1.28 (95% CI,
1.12-1.46), and 1.33 (95% CI, 1.15-1.54) for females who
slept 8–8.9 hours, 9–9.9 hours, ≥10 hours, respectively,
compared with females who slept 7–7.9 hours. To better
understand and provide valuable clues to explain the rela-
tionship between daily sleep duration and MetS, we further
analyzed nighttime sleep duration or daytime napping dur-
ation on the risk of MetS using a series of logistic regres-
sion models (Table 3). Nighttime sleep duration was not
associated with MetS in all three models after adjusting for
demographic factors, heath-related life behaviors, disease
history, and daytime napping duration in either males or
females. With regard to the association between daytime
napping duration and MetS, model 1 showed that longer
daytime napping durations of ≥ 90 minutes (OR, 1.22 [95%
CI, 1.09-1.36]) had a risk of MetS compared with those
who never napped in the daytime in females, while shorter
napping time (<90 minutes) had no effects on the risk of
MetS (Table 3), after adjusting for demographic factors,
heath-related life behaviors, self-reported physician-
diagnosed chronic diseases and a family history of diabetes
or hypertension. Model 2 showed that longer napping dur-
ation of ≥ 90 minutes (OR, 1.17 [95% CI, 1.08-1.27]) still
was associated with higher risk of MeSt after adjustment
for BMI in females. When nighttime sleep duration was




) 370 (63.8) 210 (36.2)
.6) 1473 (66.3) 749 (33.7)
.6) 2928 (62.5) 1759 (37.5)
.0) 2380 (59.6) 1613 (40.4)
.4) 1337 (57.3) 995 (42.7)
0.19 0.005
.0) 738 (64.3) 410 (35.7)
.7) 2470 (63.1) 1445 (36.9)
3.6) 3529 (60.4) 2316 (39.6)
.9) 1751 (60.3) 1155 (39.7)
0.08 <0.001
.4) 2996 (63.9) 1690 (27.9)
) 372 (72.1) 144 (27.9)
.2) 1515 (17.8) 922 (37.8)
.4) 2303 (27.1) 1577 (40.6)
.3) 1302 (15.3) 993 (43.3)
Table 3 Adjusted odds ratios (95% CI) for metabolic
syndrome by sleep duration stratified by gender
Model 1 Model 2 Model 3
Daily sleep duration (hours)
Male
<7 1.21 (0.91-1.61) 1.28 (0.90-1.80)
7-7.9 1.00 1.00
8-8.9 0.99 (0.85-1.16) 1.14 (0.95-1.37)
9-9.9 0.94 (0.80-1.09) 1.12 (0.93-1.34)
≥10 1.08 (0.92-1.26) 1.10 (0.98-1.38)
Female
<7 1.13 (0.92-1.39) 1.06 (0.84-1.35)
7-7.9 1.00 1.00
8-8.9 1.16 (1.04-1.30) 1.20 (1.06-1.37)
9-9.9 1.22 (1.08-1.36) 1.28 (1.12-1.46)
≥10 1.29 (1.13-1.46) 1.33 (1.15-1.54)
Nighttime sleep duration (hours)
Male
<7 1.22 (1.01-1.46) 1.15 (0.93-1.44) 1.04 (0.93-1.17)
7-7.9 1.00 1.00 1.00
8-8.9 0.99 (0.89-1.11) 1.13 (0.99-1.29) 1.04 (0.97-1.12)
≥9 1.01 (0.89-1.14) 1.28 (1.10-1.49) 1.01 (0.94-1.10)
Female
<7 0.96 (0.83-1.11) 0.94 (0.79-1.11) 0.93 (0.79-1.10)
7-7.9 1.00 1.00 1.00
8-8.9 1.08 (0.99-1.18) 1.06 (0.96-1.17) 1.05 (0.96-1.16)
≥9 1.04 (0.93-1.15) 1.10 (0.97-1.24) 1.10 (0.97-1.24)
Daytime napping duration (minutes)
Male
None 1.00 1.00 1.00
<30 1.05 (0.79-1.40) 0.94 (0.67-1.33) 0.94 (0.67-1.33)
30-59 1.03 (0.89-1.19) 1.07 (0.90-1.28) 1.07 (0.90-1.28)
60-89 1.09 (0.97-1.23) 1.05 (0.91-1.22) 1.05 (0.91-1.22)
≥90 1.12 (1.00-1.28) 1.09 (0.94-1.27) 1.09 (0.94-1.27)
Female
None 1.00 1.00 1.00
<30 0.92 (0.73-1.10) 0.87 (0.75-1.02) 0.88 (0.74-1.03)
30-59 1.02 (0.92-1.14) 1.03 (0.97-1.20) 1.03 (0.91-1.16)
60-89 1.10 (1.00-1.21) 1.08 (0.97-1.20) 1.08 (0.97-1.20)
≥90 1.22 (1.09-1.36) 1.21 (1.06-1.37) 1.20 (1.06-1.37)
Model 1, adjusted for age, marriage, education, smoking status, drinking
status, physical activity, coronary heart disease, myocardial infarction, stroke,
and family history of hypertension or diabetes.
Model 2, adjusted for the variables in model 1 plus body mass index (BMI).
Model 3, adjusted for the variables in model 2 plus daytime napping duration
or nighttime sleep duration, as appropriate.
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ation, nighttime sleep duration and daytime sleep duration
were not associated with MetS among males.
The logistic regression analyses of the relationship be-
tween daily sleep duration and the components of MetS
showed that long daily sleep duration was independently
associated with its components as well except for central
obesity in females. Among males, longer daily sleep dur-
ation was associated with higher risk of HDL-C criteria
only (Table 4).
Discussion
With a large sample size, we provided epidemiological
evidence that long daily sleep duration (≥8 hours) is as-
sociated with MetS, while short daily sleep duration (<7
hours) was not associated with MetS in middle-aged and
older Chinese females after adjustment for potential
confounders. Moreover, longer daily sleep duration ap-
pears to have an adverse effect on the components of
the MetS, including triglyceride, HDL-C, blood pressure
and glucose. Interestingly, further analysis revealed that
longer daytime napping (≥90 minutes) rather than lon-
ger nighttime sleep is independently associated with a
higher risk for MetS.
Few studies have investigated the relationship between
the combined sleep duration of nighttime sleep and day-
time napping and MetS. The findings of the current
study were consistent with one recent study which re-
ported that Korean females who slept ≥9 h/d had 1.43
times higher risk of MetS compared with those who
slept 7 h/d [16]. Teresa et al. explored the relationship
between total sleep duration and MetS in 29,333 Chin-
ese adults ages 50–96 years and found that participants
who slept longer (≥8 h/d) were more likely to have MetS
and its components [17]. However, Teresa et al. did
not revealed gender-specific associations between total
sleep duration and MetS or further analyze the relation-
ships among nighttime sleep duration, daytime napping
duration and MetS. The reasons for the gender-specific
associations are unclear. One explanation may be hormonal
differences and the effects of hormones on sleep [18].
Middle-age females progressing the menopausal transition
is significantly associated with difficulty sleeping [19].
Older females with decreasing estrogen levels were found
to be associated with more trouble falling asleep and fre-
quent awakening [15]. Thus, the association between long
sleep duration and MetS may be amplified in females. In
addition to the physiological explanation, there have been
reported that differential social-economic characteristics
and social roles of males and females could lead to the dif-
ference of sleep quality [20].
Our findings indicated that neither long nor short
nighttime sleep is related to the prevalence of MetS in
females and males. The association between nighttime
Table 4 Adjusted odds ratios of the components of metabolic syndrome by daily sleep duration per day stratified by
gender
Duration of daily sleep (hours/day)
<7 7~ 8~ 9~ ≥10
Male
Central obesity criterion 1.26 (0.95-1.65) 1.00 0.93 (0.80-1.07) 0.90 (0.80-1.05) 0.89 (0.77-1.04)
Glucose criterion 0.93 (0.71-1.22) 1.00 0.92 (0.81-1.06) 0.99 (0.87-1.15) 1.10 (0.96-1.28)
Blood pressure criterion 0.87 (0.65-1.16) 1.00 0.98 (0.84-1.13) 0.95 (0.82-1.10) 1.05 (0.90-1.67)
HDL-C criterion 1.26 (0.88-1.80) 1.00 1.23 (1.01-1.49) 1.22 (1.01-1.48) 1.40 (1.15-1.71)
Triglycerides criterion 1.00 (0.75-1.35) 1.00 0.99 (0.85-1.15) 1.12 (0.97-1.30) 1.17 (0.99-1.36)
Female
Central obesity criterion 1.05 (0.85-1.29) 1.00 1.11 (0.99-1.24) 1.08 (0.96-1.21) 1.04 (0.91-1.19)
Glucose criterion 0.81 (0.66-1.00) 1.00 0.98 (0.88-1.09) 0.96 (0.86-1.08) 1.18 (1.04-1.34)
Blood pressure criterion 1.00 (0.80-1.24) 1.00 1.08 (0.96-1.22) 1.10 (0.97-1.24) 1.18 (1.02-1.36)
HDL-C criterion 0.99 (0.79-1.24) 1.00 1.02 (0.90-1.15) 1.14 (1.01-1.29) 1.21 (1.05-1.39)
Triglycerides criterion 1.07 (0.85-1.33) 1.00 1.05 (0.93-1.18) 1.11 (0.98-1.26) 1.15 (1.00-1.32)
Adjust for age, marriage, education, smoking status, drinking status, physical activity, coronary heart disease, myocardial infarction, stroke, and the other four
components of metabolic syndrome as appropriate.
HDL-C, high-density lipoprotein cholesterol.
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indicated that both short and long sleep duration is
correlated to the risk of MetS, suggesting a U-shaped
pattern [21,22]. Several studies demonstrated that the
risk of MetS increased with short nighttime sleep dur-
ation only [23-25]. Another study reported that only
long nighttime sleep duration was associated with ele-
vated risk for MetS [26]. There were several possible rea-
sons for observing a nonsignificant relationship between
nighttime sleep duration and MetS in our study. First,
unlike the studies mentioned above, all the participants
of our study were middle-aged and older retired adults
who have more time to sleep and less chance for sleep
restriction due to retirement. Only 7.8% of participants
slept less than 7 hours per night and only 3.7% of partic-
ipants slept less than 6 hours per night, which may have
contributed to the lack of power in this study. Second,
as for the components of MetS, we found that longer
nighttime sleep duration was a risk factor for reduced
HDL-cholesterol and elevated triglycerides, while it was
a protective factor for central obesity (data not shown).
This opposing direction of the associations between
nighttime sleep duration and the components of MetS
might be one explanation for the absence of a relation-
ship between nighttime sleep duration and MetS.
Few studies have examined the association between day-
time napping and MetS. Lin et al. found that a longer day-
time napping duration but not a longer nighttime sleeping
duration was associated with a higher risk for MetS in fe-
males, which was consistent with our findings [12]. Com-
pared with the study of Lin et al., our study has the
strength of large sample size and abundant covariates.Data from 16,480 older adults from the Guangzhou Bio-
bank Cohort Study revealed that a higher frequency of
daytime napping was independently related to an in-
creased risk of MetS [11]. However, they assessed the fre-
quency of daytime napping rather than the duration of it.
The mechanism underlying the association between lon-
ger daytime napping duration and MetS is unclear. Sleep
could have various influences on metabolism and endo-
crine secretion patterns by interfering with the circadian
rhythm [27,28]. Circadian rhythm disturbances arising
from excessive daytime napping could be one explanation
for the relationship between longer daytime napping dur-
ation and MetS. Circadian rhythm disturbances can lead
to insulin resistance, which plays a major role in the devel-
opment of MetS and is almost always present with other
metabolic abnormalities [29,30]. Another physiologic
pathway which plays a role in the relationship between
daytime napping and MetS may be sympathetic activation
[31]. It has been reported that the practice of napping can
induce the elevation of blood pressure mediated by sym-
pathetic activation [32]. Indeed, the sympathetic nervous
system is crucial in circulatory and metabolic control and
was found to be associated with MetS [33]. Previous stud-
ies have reported that long daytime sleep duration was
associated with an increased risk for cardiovascular mor-
tality in the elderly [10,34]. The presence of MetS carries
an elevated risk of cardiovascular disease [3]. Therefore,
our results may provide a mechanism linking longer
daytime sleep duration and cardiovascular mortality via
mediation of MetS.
Several potential limitations of our study need to be
mentioned. First, we collected the information about
Wu et al. BMC Public Health  (2015) 15:178 Page 7 of 8sleep duration based on self-reports. Despite high corre-
lations between subjective estimates of sleep duration
and more direct assessments such as actigraphy [35,36],
other objective measurements of sleep duration are
needed to support our findings. Secondly, the cross-
sectional design limits causal inferences on the associ-
ation between sleep duration and MetS. However, in the
Chinese context, daytime napping is considered healthy
and most Chinese develop the habit of daytime napping
in youth [37], making the reverse association unlikely in
this case. Third, we did not include other potential
confounders that could affect sleep patterns such as ob-
structive sleep apnea (OSA). OSA is independently cor-
related with insulin resistance and a high risk of MetS,
and is known to cause excessive sleepiness [38,39], with
habitual nappers having a higher frequency of OSA [40].
Missing data on these crucial factors could inevitably
lead to potential bias in the evaluation of the odds ratios
for MetS. Finally, this study was performed in a Chinese
population, and our results might not be able to be gen-
eralized to other races and ethnic groups.
The strengths of our study include a large sample size;
the availability of blood measurements; the abundant data
on potential confounding factors; and standardized ques-
tionnaires, which not only enhance the precision but also
allow statistical adjustment for multiple variables.
Conclusions
Longer daytime napping duration rather than nighttime
sleep duration is associated with a moderate elevated risk
of MetS in females. The findings have significant implica-
tions for further study to examine the appropriate dur-
ation of sleep for older adults especially for females.
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